Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Arix Bioscience plc
  6. Financials
    ARIX   GB00BD045071

ARIX BIOSCIENCE PLC

(ARIX)
  Report
Delayed London Stock Exchange  -  11:35:09 2023-02-03 am EST
108.00 GBX   +2.86%
01/26Arix Bioscience plc Announces Resignation of Benny Soffer as Non-Executive Director
CI
01/05Arix Bioscience Acquires Core Portfolio Company Twelve Bio
MT
01/05Ensoma, Inc. announced that it has received $85 million in funding from a group of investors
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusFunds 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 208134286151134134
Enterprise Value (EV)1 11780,117415117,8134
P/E ratio 5,61x-1,98x2,47x---
Yield ------
Capitalization / Revenue 156 558 483x264 354 209x599 284 413x---
EV / Revenue 87 870 230x158 263 300x364 867 222x---
EV / EBITDA ------
Enterprise Value (EV) / FCF ------
FCF Yield ------
Price to Book 0,83x0,71x0,91x---
Nbr of stocks (in thousands) 124 871125 599130 529124 099124 100124 100
Reference price (GBP) 1,671,072,191,221,081,08
Announcement Date 03/28/201903/10/202003/09/2021---
1 GBP in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1,330,510,48---
EBITDA ------
Operating profit (EBIT) 40,8-70,6128---
Operating Margin 3 073%-13 959%26 831%---
Pre-Tax Profit (EBT) 42,8-75,6126---
Net income 36,9-69,9126---
Net margin 2 777%-13 808%26 431%---
EPS 0,30-0,540,89---
Free Cash Flow ------
FCF margin ------
FCF Conversion ------
Dividend per Share1 ------
Announcement Date 03/28/201903/10/202003/09/2021---
1 GBP
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2022
Net Debt1 ----
Net Cash position1 91,253,7112116
Leverage (Debt / EBITDA) ----
Free Cash Flow ----
ROE (Net Profit / Equities) ----
Shareholders' equity ----
ROA (Net Profit / Asset) ----
Assets ----
Book Value Per Share 2,001,492,42-
Cash Flow per Share ----
Capex 0,000,010,01-
Capex / Sales 0,15%1,19%1,47%-
Announcement Date 03/28/201903/10/202003/09/2021-
1 GBP in Million
Estimates
Key data
Capitalization (GBP) 134 028 235
Capitalization (USD) 162 100 862
Net sales (GBP) -53 578 000
Net sales (USD) -64 800 077
Number of employees 7
Sales / Employee (GBP) -7 654 000
Sales / Employee (USD) -9 257 154
Free-Float 69,0%
Free-Float capitalization (GBP) 92 497 491
Free-Float capitalization (USD) 111 871 376
Avg. Exchange 20 sessions (GBP) 7 965 362
Avg. Exchange 20 sessions (USD) 9 633 731
Average Daily Capital Traded 5,94%
EPS & Dividend